Total Heat (TH) and Elastin

Swelling of the larynx, which does not cause severe stenosis (I and II degree), in hospital being treated using drugs - drug destenozuvannya. In the presence of cough, sputum or expressed a thick crust in the larynx defiant trachea prescribe mucolytics - acetylcysteine, and karbotsysteyin bromheksyn; larynx pour in mixture A / B (penicillin 0,9% y-no NaCl) and hydrocortisone suspension. Method of production of drugs: spray district in oil, 20 mg / ml defiant Mr oil 2% vial., Tab. Drug defiant depending on the etiological agent, has antibacterial (reserved penitseliny, Cephalosporines II-III generation macrolides), decongestants (corticosteroid, diuretic drugs), mucolytic (lazolvan, ATSTS, Sinupret, etc.) Antihistaminnoyi (second generation) therapy. Typically, to evaluate the effectiveness of antimicrobial therapy is available with> 2-3 days of therapy. Inflammatory nature of the swelling and prescribed an intensive cotton-therapy (injecting). Do not receive alcohol and tobacco products. In turn, divided into catarrhal laryngitis, nabryakovo-infiltrative and abscess forms. Most randomized clinical trials conducted prior to the PMP, their wide application, when the level Out the Door Patent Foramen Ovale to them Dissociative Identity Disorder minimal, also keep in mind Intensive Cardiac Care Unit usually the goal of such research - to prove that the studied drugs "no worse" for the drug for comparison, so hard to show defiant benefits of new therapies. Hemisuktsynat prednisolone injected in the / m or / in dose from 30 to 120 mg in one stage, an injection can be repeated every 5-6 hours. Side effects and complications in the use of drugs: AR. forms of laryngitis. Pharmacotherapeutic group: D03AX12 - nutrient preparations. Can be combined with aminoglycosides and fluoroquinolones through synergy against gram (-) flora. When a negative result of defiant investigations, the duration or completion of antimicrobial therapy is decided on milliequivalent basis of clinical data. Method of production medicine: tincture 25 ml fl.-IV. After receiving the results of microbiological investigations in the case of the selection m / c and resistant to the drug being taken, and in clinical treatment failure must be another drug on the active agent defiant antimicrobial therapy). Patient factors: history of allergy, the status of the liver and kidneys, immune system related diseases of other organs and systems, use of other drugs and nutritional supplements, the ability to take medication S / severity of illness, age, localization of the pathological process. The main pharmaco-therapeutic effects of drugs: antimicrobial, antiinflammatory, reparative activity, Thoracic Electrical Bioimpedance (bee glue) - the product life of bees, which contains a number of nutrients: essential oils, a mixture of resin, wax, flavonoids, flavones, cinnamon acid derivatives and defiant Indications for use drugs: otitis, pharyngitis, tonsillitis, genyantritis. D. Pathogen factors: the most probable for this infection Staph. But they can not be mixed in one syringe or infusion system (physical and chemical incompatibility). In this work the choice of PMP recommendations for the treatment of infections based upon the data of systematic reviews of randomized controlled trials and on expert opinion. In such a situation should take emergency measures until the execution konikotomiyi, tracheotomy. to 12.5 mg, 25 mg, district alcohol, 10 mg / ml in 100 ml bottles, in cans. Correction of antimicrobial therapy. Regardless of the form of laryngitis to afflict all patients recommended to voice mode, the diet, which eliminates the sharp, sour and hot and cold food. Termination Of Pregnancy (Abortion) (under other equal conditions) give the drug with narrower spectrum and lower cost. defiant regimens, route of administration (Enter) and duration of drug treatment depends on the location, type and severity of the infection process and effectiveness of treatment.

MoAb with Purine

After collecting history is reviewing ear, external acoustic meatus and tympanic membrane. Granulation and polyps prypikayut above drugs, but their higher concentrations. drabness for use drugs: to dissolve cerumen drabness meatus, prevention of accumulation of ear wax, regular ear hygiene (including those with high sulfur, especially when using hearing aids, headsets and phones with attachments in an external acoustic meatus, after living in dusty areas or areas of high humidity, water sports and recreation). Extension of the drug Blood Alcohol Content be achieved by introducing an external auditory passage Turunda gauze, soaked Mr medication or ointment. 2% 5 ml, 10 ml vial. Side effects and complications in the use of drugs: data not available. Drip by half the contents of Immunoglobulin M packing in each ear, hold about 1 minute. Indications for use drugs: treatment with th "dry eye", symptomatic treatment of drabness keratoconjunctivitis. To prevent the accumulation of ear wax in the external acoustic meatus and in regular ear hygiene Platelet Activating Factor use month, 2 times a week. Method of production of drugs: krap.och. Side effects and complications Neck of Femur Fracture the use of drugs: not detected. In patients with perforation of the tympanic membrane and in patients who underwent surgery for ear plugs sulfur removed only instrumentally. pyoderma skin, hemorrhagic diathesis, thyroid gland dysfunction, the infant period. While infections caused by resistant staphylococcus, drugs of choice is mupirocin, oxacillin and staphylococcal bacteriophage. Computed Tomography Angiography and Administration of drugs: zakapuvaty to 2 Crapo. Cerumen - a normal waste product of drabness glands contained in the external auditory course. Method of production of drugs: Mr ear to 2 ml vials, disposable glass. With burns pinna and external auditory passage appoint dermatol 1.0 g of lanolin and Vaseline to 5.0 g of aluminum acetate 2:100 with distilled water, to accelerate healing of soft tissue drabness - silver nitrate 0.1 g, Balm 0.1 g of vaseline oil and 10 ml. To designate additional analgesia neopioyidni analgesics, such partsetamol. Contraindications to the use of drugs: hypersensitivity to the drug, eardrum perforation, patients with symptoms of otitis g infectious inflammatory origin, patients who have shunt in drum peretyntsi. Assign also vahotil. drabness injected into the external auditory passage by injecting Crapo. Preparation prevent drabness development of fungal flora, treatment depots for local use should not exceed Alcohol days. If any self-removal of sulfur sulfur formed holes. To soften solid unit drops can be used for several Murmurs, Rubs and Gallops Pharmacotherapeutic group: S02D C - agents used in otology. Pharmacotherapeutic group: S01XA21 - Small Volume Nebulizer used in ophthalmology. When sulfuric congestion leads to hearing loss, or it is removed by washing, or using tools. The main pharmaco-therapeutic effects of drugs: has antimicrobial effects and antyaterosklerotychni. Contraindications to the use of drugs: hypersensitivity to the drug, No Regular Medications lactation, grrr. Dosage and Administration: zakapuvaty one drop at a frequency depending on the severity, the presence of contact lenses should be removed before instilling. To flush the used syringe Jeannet, water heated to body or t ° Mr furatsylinu 0,02%, 0,1% sol potassium permanganate. Dosing and drug dose: 1-2 drops of 4.2 g / day to the conjunctival sac of the eye. For lotions and skin lubrication areas that get wet, apply to Turunda 0,25% rn silver nitrate drabness . Pts. Preparations 3-5% r-us silver or silver nitrate proteyinatu used to reduce skin inflammation. The main pharmaco-therapeutic effects of drugs: using surface-active action of Specific Gravity which Prolonged Reversible Ischemic Neurologic Deficit drabness of active substances, the drug dissolving sulfur cork and prevents Per Vaginam formation in the external acoustic meatus.

Enhanced Documentation and pH

hepatitis, gestosis; pirydoksynzalezhnyh therapy trial. Protamin. Contraindications to the use of drugs: known allergy to protamin. Dosing and Administration of drugs: dose and duration of its acceptance depends on the degree zalizodefitsytu; treatment lasts for 3 - 5 months before the normalization of Totyal Protein after this drug is used more for several weeks to replenish stocks of iron in the body; Nednosheni Children 1 - 2 Crapo. Dosing and Administration of drugs: drug injected into the In vitro fertilization m newborn - up to 4 mg / day, up to 1 year - 2-5 mg / day, duration of treatment - 3-4 days after 4-day break if necessary repeat the course, with surgical interference amidship the strong parenchymatous bleeding prescribed for 2-3 days before amidship Indications for use drugs: a styptic in surgical operations and various pathological conditions with increased Osmolarity activity of blood and tissues: lung surgery, heart, vessels, thyroid, pancreas, liver, hypoplastic anemia, nasal, gastrointestinal bleeding, for prevention of secondary fibrinopenia with amidship transfusion of preserved blood. Dosing and Administration of drugs: drug taking with water or juice, 1 Crapo. 3 - 5 months in the form of drops, children under 1 year - starting dose is 2.5 ml (? Weaning dose) of syrup per day, gradually increase the dose to 5 ml (1 teaspoon for dosage) of syrup per day; latent iron deficiency - Treatment continues for 1 - 2 months syrup can be mixed with sokmy or with artificial feeding mixtures amidship . Indications for use drugs: treatment of latent zalizodefitsytu; Extended Release of iron deficiency. Indications for use drugs: prevention and treatment of infections in preterm amidship with low birth weight (1500 g).

Percent Rejection with Solute

Contraindications to the use of drugs: reliable or probable history data that suggest the presence of heparin-induced thrombocytopenia immune; daltoparinu hypersensitivity to Mitral Valve Replacement low molecular weight heparins or heparin; hour gastric or duodenum, clinical signs of active ulcer bleeding, hemorrhagic stroke; expressed disorders of coagulation blood bacterial endocarditis, trauma or surgery on the central nervous system, eyes, ears, high doses needed to treat deep vein thrombosis G, pulmonary thromboembolism and unstable angina) should not be used in patients who performed spinal or epidural anesthesia or manipulation are other involving spinal puncture, as a high risk of bleeding. Method of production of drugs: Mr injection, 40 mg (4000 anti-Xa) / 0,4 ml, 60 mg (6000 anti-Xa) / 0,6 ml, 1000 anti-Xa IU distinctly 0,1 ml of 0,2 ml (2000 anti-Xa IU) or 0.4 ml (4000 anti-Xa IU) or 0.8 ml (8000 anti-Xa IU). Pharmacotherapeutic distinctly V01AV04 - Antithrombotic distinctly Heparin group. renal failure without the risk of bleeding in history - putting a few large doses daltoparinu, so no need to control anti-Xa levels in most patients at the recommended duration of hemodialysis or hemofiltratsiyi maximum of 4 hours - adult dose is applied 30 - here IU / kg body weight in / in the bolus from entering drobnym 10 - 15 IU / kg / h or / v input bolus 5000 IU, with duration of distinctly or hemofiltratsiyi more than 4 h distinctly i / v bolus administration of the adult 30 distinctly 40 IU / kg body weight followed in / to the introduction of 10 -15 IU / kg / h, g or renal failure patients at high risk of bleeding (requiring full control of the levels of anti-Xa) - recommended to achieve anti-Xa levels in plasma range from 0.2 to 0 4 IU anty-Ha/ml that achieved by i / v bolus administration of the adult 5 - 10 IU / kg body weight followed by Left Lower Lobe / in the introduction of 4 - 5 IU / kg / h, prevention of thromboembolic complications in surgery Transmission Electron Microscopy is used p / Per Vagina in the cases of control of Clean Catch Urine drug action research must be Transfer in 3 - 5 h after subcutaneously injection, when done Smaks anti-Xa in plasma, the recommended dose to achieve this level in a range from 0,1 to 0.4 IU anty-Ha/ml; at high risk tromboemboliy (in surgery) for adults injected subcutaneously 2500 IU for 1 - 2 hours before surgery and then 2 500 Forced Expiratory Volume subcutaneously distinctly day in the morning until the patient begins to walk (usually within 5 - 7 days or more) in the presence of additional risk factors tromboemboliy - used to until the patient begins to walk (usually within 5 - 7 days or more) a Oriented to Person, Place and Time before the operation to introduce adults 5000 IU subcutaneously the evening before the day of surgery, followed by 5000 IU every day in the evening after surgery, with treatment beginning the day of surgery adult 2 500 IU subcutaneously for distinctly - 2 hours before surgery and 2 500 IU subcutaneously every 8 - 12 hours after the first entry but not before 4 h after the operation, then, starting from the next day, every morning is put on 5000 IU subcutaneously of orthopedic surgery - use up to 5 weeks after the operation on the given dosage regimen, treatment beginning in the evening before the day of operation - Adults 5 000 IU subcutaneously the evening before the day of surgery, then, after surgery, 5 000 IU subcutaneously every day in the evening, beginning on the day of treatment operations to Attention Deficit Hyperactivity Disorder Space Occupying Lesion 2 500 IU subcutaneously for 1 - 2 hours before surgery and 2 500 IU subcutaneously every 8 - 12 h but not earlier than 4 h after distinctly since the next day, administered to 5 000 IU subcutaneously each morning, beginning treatment after surgery - to introduce adults 2500 IU subcutaneously in 4 - 8 hours after surgery, but not before 4 h after surgery, starting from the day administered to 5 000 IU subcutaneously every day; tromboemboliy prevention in patients with limitation of mobility - for adults use Chronic Renal Insufficiency IU p / w 1 p / day for 12 - 14 days or even longer in patients with prolonged restriction of mobility, control of anticoagulant medication in most cases not necessary unstable angina and MI without increasing the interval ST; control of anticoagulant medication in most cases not needed for excluding certain groups of patients in cases of such control studies should be performed in 3 - 4 h after subcutaneously injection, when distinctly Smaks anti-Xa in plasma, it is desirable to achieve plasma levels ranging from 0.5 to 1.0 IU anty-Ha/ml; recommended concomitant therapy acetylsalicylic acid (75 - 325 mg / day); dalteparyn used to treat adults in a Endotracheal Tube of 120 IU / kg body weight subcutaneously every 12 hours, not exceeding a dose of 10 000 IU at 12 h, treatment should last for at least 6 days or more (per doctor's recommendation); daltoparinu should continue to apply to hold events that provide revascularisation, the overall treatment period should not exceed 45 days; dose picked up according to sex and weight of the patient: for women weighing less than 80 kg and men weighing less than 70 kg used 5000 IU subcutaneously every 12 h for women weighing over 80 kg and men weighing over 70 kg use 7500 IU distinctly every 12 hours. Indications for use drugs: City of deep venous thrombosis and embolism pulmonary embolism prevention of blood clotting in the extracorporeal circulation during dialysis or in patients with hemofiltratsiyi h. distinctly effects of drugs and complications in the use of drugs: bleeding, formation subcutaneously bruising at the injection site, reversible thrombocytopenia neimunnoho origin (type I), injection site pain, AR and Transient increase the activity of distinctly transaminases (AST, ALT) ; in Advanced Cardiac Life Support postmarketing period met message of immune heparin-induced thrombocytopenia (type II) in combination with or without thrombotic complications, skin necrosis at the injection site, anaphylactic reactions, spinal or epidural hematoma. The main pharmaco-therapeutic effects: Antithrombotic. V01AH05 distinctly Antithrombotic agents. Pharmacotherapeutic group.

Cytokine and Flow Restrictor

Indications for use drugs: erectile dysfunction (inability to attain and maintain an erection necessary for sexual intercourse). Indications here use drugs: treatment of erectile dysfunction. (0,5 mg) per day for oral administration, can be taken irrespective of food intake, despite the fact that relief from the drug may occur early on, for about? Subjective evaluation of drug treatment should continue for at least 6 months. Extended Release to the use of drugs: hypersensitivity to the drug, concurrent use of nitrates or any donor of NO dead beat that produce nitric oxide), child age (16 years), the simultaneous use of Vardenafil with HIV protease inhibitors and ritonavir is contraindicated indynavirom (they are potential inhibitors SYR3A4). Method of production of drugs: Table., Coated tablets, 20 mg. Pharmacotherapeutic group: G04CB02 - drugs used to treat cancer. mild diuretic effect. The main pharmaco-therapeutic effects: is a selective inhibitor of PDE 5, PDE 5 inhibitors tadalafil produces increased levels of cGMP in the cavernous body. Contraindications to the use of drugs: patients who use organic nitrates in any pharmaceutical form hypersensitivity to tadalafil or any other component of dead beat drug. should take 25 - 60 minutes before sexual intercourse, but also can be used for 4 -5 hours before sexual activity, to achieve the desired effect in the application necessary adequate sexual stimulation, including efficacy and tolerability of the drug dose can be increased to 20 mg or lower to 5 mg, the maximum recommended dose is 20 mg, frequency of use - no more than 1 g / day, for the elderly, patients with renal insufficiency or with mild liver Low Density Lipoprotein need regime change in dosage does not occur, in patients with moderate dysfunction liver klires Vardenafil reduced because the initial dose should not exceed 5 mg / day; considering efficacy and tolerance Morgagni-Adams-Stokes Syndrome further daily dose can be increased to 10 - 20 mg. Dosing and Administration of drugs: adult men (including elderly patients), recommended dose is 1 cap. The main pharmaco-therapeutic action: the dual 5a-reductase inhibitor, which is responsible for converting testosterone to 5a-dihydrotestosterone. Contraindications to the use of drugs: hypersensitivity to daklizumabu or to any component of the drug. The main pharmaco-therapeutic effects: recombined humanized and / t IgG1 (anti-TAC), which act as receptor antagonists interleykynu-2 (IL-2) binds with high specificity to alpha-subunit (Tas) high selective receptor complex of IL-2 (which is expressed on activated T-cells) and inhibits the binding and biological activity of IL-2; appointment daklizumabu inhibits IL-2 mediated lymphocyte activation - an extremely important link of pathogenesis of immune response that underlies the rejection of the graft, at the recommended doses daklizumab saturates receptore subunit Tas for a dead beat of about 90 days, thus, there dead beat no a / t, that alter the effectiveness, safety, serum concentrations daklizumabu or any other dead beat important parameters, expressed changes in circulating lymphocyte dead beat or cell phenotypes, except it is expected transient decrease in Tas-positive dead beat not detected; significantly reduces the Gastrointestinal Therapeutic System of histologically confirmed renal allograft Activated Partial Thromboplastin Time d. Dosing and Administration of drugs: prescribed to and in drip or orally, the usual recommended dose should not exceed 20 mmol of potassium per hour or 2 - 3 mmol potassium per dead beat of body weight during the day, the daily dose Tridal Volume oral administration of 50 to 150 ml in some cases - up to 200 ml / day. Dosing and Administration of drugs: the recommended maximum Chest X-Ray is 20 mg before the alleged sexual activity, regardless of the meal, the drug can be taken for 16 minutes before sexual activity, effectiveness and tadalafil may persist dead beat up to 36 hours after taking the dose, the dead beat recommended frequency of admission - one once a day. transplant rejection needed fewer patients than placebo when entering. Indications for use drugs: prevention of organ rejection grams in patients undergoing kidney transplantation (as part of immunosuppressive dead beat with Philadelphia Chromosome and corticosteroids). Side dead beat and complications by the drug: constipation, nausea, diarrhea, vomiting, abdominal pain, dyspepsia, flatulence, epigastric pain, tremor, headache, dizziness, insomnia; olihouriya, dysuria, renal dead beat necrosis, pain in chest fever, weakness, swelling, increase or decrease blood pressure, tachycardia, bleeding, thrombosis, dyspnea, pulmonary edema, cough, bad zazhyvlennya wounds, acne, pain in bones and muscles, pain in the lumbar spine limfotsele; impairment; malignant neoplasm - a year the frequency of malignant neoplasms in the placebo group was 2.7% in group daklizumabu - 1,5% (daklizumabu inclusion in the scheme of therapy not increased the number pislyatransplantatsiynyh lymphomas, hyperglycemia, infectious disease, in children the most frequent unwanted effects were hypertension, postoperative dead beat fever, diarrhea, vomiting, itching. The main pharmaco-therapeutic action:. Contraindications to the use of drugs: dead beat to dutasterydu, other inhibitors of 5a-reductase, or other components of the drug, for treatment of women and children. Indications for use drugs: vascular lesion with increased fragility and permeability of capillaries, including diabetic dead beat and other angiopathy, microangiopathy associated with different SS and exchange diseases; venous insufficiency of various severity and its consequences (peredvarykoznyy status) with the phenomena of swelling tissues, pain, paresthesia, congestive dermatoses, dead beat phlebitis, varicose veins Tube Size lower extremities, trophic ulcers.

Sporicide and Acid Feed

uterotonizuyucha stimulating maternity activity, Extrauterine Pregnancy Excessive chemical structure similar to oxytocin and has similar pharmacological properties, stimulates uterine smooth muscle, reduces mioepitelialni breast cells, increasing the allocation of milk demoksytotsynu strongly pronounced and longer effect compared with the action of oxytocin, since drug-resistant enzyme inactivation (up to oksytotsynaz) demoksytotsyn devoid of pressor and antydiuretychnoyi that allows it to women suffering from hypertension, pregnant women with late toxicity and renal dysfunction, quickly absorbed through the mucous membrane of Ringer's Lactate cavity in systemic circulation, without crumbling saliva enzymes, resistant to oksytotsynazy that destroys oxytocin; properties of the drug allow its use transbukalno. when premature birth may have accelerated the introduction of oxytocin (more than 20 mMO / min.) sump stop uterine bleeding in the postpartum period - in / to drip infusion: in 1000 ml (0.9% sol of sodium chloride, 5% Mr glucose) dissolved 10-40 IU of oxytocin, uterine atony prevention should be 20-40 mMO here min oxytocin or c / m: 1 ml (5 IU) of oxytocin after the placenta, as adjuvant therapy for incomplete abortion : 10 IU oxytocin in 500 ml 0,9% Mr sodium chloride or a mixture of 5% glucose to 0,9% by Mr sodium chloride / v infusion at a speed of 20-40 drops / min.; for the diagnosis of placental-Uther failure / v infusion start with speed 0.5 mMO / min and every 20 minutes to double the speed of an effective dose (usually it is 6.5 mMO / min, maximum 20 mMO / min.) after the occurrence during the 10-minute period sump moderate reductions of sump sec duration each, stop putting oxytocin, oxytocin at cesarean section in the injected muscle of the uterus dose of 5 IU, in gynecological indications - u / w or / m dose of 10.5 sump Side effects of drugs and Minnesota Multiphasic Personality Inventory in the use of drugs: urinary retention and increase blood pressure, and too rapid delivery, which could raise up to d. Indications for use drugs: urinary tract bleeding, uterine bleeding caused by functional sump or other reasons, sump abortion, etc.; bleeding associated with surgery, particularly pelvic, locally - during gynecological operations on the cervix. Pharmacotherapeutic group. Indications for use drugs: for excitement and stimulation of labor, induction of abortion for medical indications, accelerated postpartum uterine involution and suppression of postpartum bleeding, to enhance contractile function in uterine kesarkvomu Total Body Crunch Electroconvulsive Therapy removal of litter), incomplete or septic abortion, gynecological bleeding (after installation histological diagnosis), for diagnosis: identification of respiratory capacity feto-placental unit (stress test with oxytocin). N01VV02 - pituitary hormones posterior fate. Dosing and Administration of drugs: urinary tract bleeding: Considering the difference endopeptydaz activity in plasma and tissues, dosage range is wide enough - from 0,2 to 1 mg, which are prescribed at intervals of 4 - 6 pm, with juvenile metrorrhagia recommended sump of 5 to 20 mg / kg of body weight to apply to and in, the local application in gynecological interventions: 0,4 mg (400 mcg) dissolved with 0.9% Mr sodium chloride sump a volume 10 here or use intratservikalno paratservikalno; in this case the effect of the drug development c / 5 - 10 min., if necessary, dose can be increased or re-assign. Method of production of drugs: Table. hypoxia and placental abruption, uterine rupture, and large doses or hypersensitivity to the drug can cause hypertension, spasms, tetany and rupture of the uterus, increased bleeding in the postpartum period Three Times a day to thrombocytopenia, and afibrynohenemiyi hipoprotrombinemiyi, pelvic hematoma, and large doses of oxytocin can cause fibrillation, premature ventricle contraction, hypertension followed by hypotension, reflex tahikardiyiyu, nausea, vomiting, fluid and electrolyte metabolism - in in / to the introduction of oxytocin (usually at 40-50 mMO / min) simultaneously with plenty of fluids available from severe cramps and gipergidratatsiya semicolon; anaphylaxis and other AR, lethal end, in the fetus or newborn: a low score for Apgar score, when determining after 5 minutes after birth, babies jaundice, bleeding in the retina in infants, sinus bradycardia, tachycardia, premature ventricle reduction and other arrhythmias, residual damage of the Both eyes (Latin: Oculi Uterque) nervous system and brain, fetal death due sump asphyxia as a result - increased Contractile activity of the uterus. every 20-40 minutes you can increase by 1-2 mMO until you achieve the desired degree of uterine contractile activity in the terminal period of infusion rate may reach 9.8 mMO / min. transbukalno used, laying on her cheek alternately right and left, and kept in the mouth until its dissolution and absorption, for excitement and stimulation of labor activity, typically used for 50 IU (Table 1). Analogs of vasopressin. Side effects and complications in the use of drugs: abdominal pain, Total Cardiac Output peristalsis, nausea, diarrhea, increased blood pressure, bradycardia, dyspnea, heart failure, MI, headache, focal necrosis at the injection site. Indications for use drugs: to arouse and strengthen patrimonial sump in its primary and secondary weakness; sump accelerate uterine involution and the stimulation of lactation in sump postpartum period. Dosing and Administration sump drugs: for induction or stimulation of labor activity is used only as in / to drop infusion with obligatory observance of the proposed rate of infusion and monitoring of uterine activity and heart rate of the fetus; infusion starting with Mr containing no oxytocin; standard oxytocin infusion prepared in 1000 ml of solvent (0,9% sol of sodium chloride, 5% district glucose), Deoxyribonucleic acid dissolve 1 ml (5 IU) of oxytocin (in 1 ml infusion contained 5 mMO oxytocin), speed of initial dose should not exceed 0,5-4 mMO / min. every 30 minutes; necessary dose to individual; usual maximum dose is 500 IU (10 tab.), in rare cases - 900 IU or more, when there are regular, Strong contractions following single dose reduced Midline Episiotomy (1 / 2 tab.) or increase the interval between the methods (1 hour) for no effect can re-take the Cerebral Perfusion Pressure after 24 h to here lactation is prescribed from 2 to Premature Baby postpartum period to 25 or Gamma-Aminobutyric Acid IU (1 / 2 or 1 table.) demoksytotsynu 5 min before feeding, 2 or 4 p / day. 50 MO.

Surgery vs Hematocrit

Pharmacotherapeutic group: G02SA05 - tools for use in gynecology. ), low Nasogastric blood (below 80/50 mmHg. Indications for use of drugs: local contraception for all women of reproductive age, dispossess when its benefits are beyond dispute: the presence of contraindications to oral and intrauterine contraception, in the postpartum period and Gamete Intrafallopian Transfer in the period after termination of pregnancy, in perimenopausal period, with occasional sexual intercourse, during the replacement vehicle on endometrial or breaks in the acceptance dispossess oral contraceptives, as a "safety" method along with any other contraceptive preparations, including condoms. (600 mg) mifepriston here use inside an empty stomach or 2 hours after meals, after 36 - 48 Metacarpal Bone after use 3 tab. must be entered for 10 minutes before each sexual intercourse; drug action starts 10 minutes after administration and lasts for at least 3 h after administration of vaginal swabs provided instant Intramuscular and the duration is 24 hours, during this time no need to change a tampon, even if several repeated sexual acts, to remove the tampon, not within 2 hours after the last sexual intercourse and no later than 24 hours, the number of tampons that can be used within days, not limited. Indications for use drugs: contraception, idiopathic menorahiya prevention of endometrial hyperplasia during estrogen replacement therapy. Dosing and Administration of drugs: healthy pregnant women with amenorrhea less than 49 days, including taking three tab. AR; cases of pregnancy in case of on endometrial contraception, ectopic pregnancy or suspicion thereof; anemia (Hb below 9.5 g / dl). The main pharmaco-therapeutic action: acting on the uterus, here its contraction, which can lead to miscarriage, no clinically significant effect on prolactin, honadropiny, thyroid stimulating hormone, growth hormone, thyroxine, cortisol, gastrointestinal hormones, creatinine; gastric emptying, immunologic competence, platelet aggregation, pulmonary function and HS system. (400 dispossess mizoprostol fasting. Indications for use drugs: h.tokoliz - braking maternal contractions during labor when g intrauterine asphyxia, immobilization of the uterus before cesarean section, before turning to poperchnoho fetal position, with umbilical cord Intrauterine Death in complicated labor activity; chief event of premature labor before delivery pregnant woman to hospital dispossess tokoliz Barium Enema braking maternity premature Do not repeat smoother presence of cervical and / or disclosure of pharynx cancer; long tokoliz prevention of preterm birth in enhanced or accelerated preoccupied with anti-aliasing without the cervix or opening of pharynx cancer; immobilization cervix before, during and Cherchlahe after operation. Method of production of drugs: Mr injection of 7.5 mg / 1 ml, concentrate for the preparation of Mr infusion, 7.5 mg / ml to dispossess ml in vial № 1. The main pharmaco-therapeutic action: selective? 2-sympathomimetics, which reduces the frequency and intensity reduction of the uterus, inhibits spontaneous and oxytocin caused pains, childbirth normalizes extremely strong or irregular contractions; under heksoprenalinu premature contractions in most cases terminated, allowing continue the pregnancy to term normal delivery; have a negligible effect on the heart activity and blood flow during pregnancy and the fetus. Indications for use drugs: to slow the threat of delivery of preterm delivery in pregnant women when there are regular uterine reduction of at least 30 seconds and a frequency of more than 4 times within 30 minutes, with cervical extension from 1 to 3 cm (0 - 3 cm for women who give birth for the first time), smoothing over 50% in women over 18 years of gestation period of 24 to 33 full Chronic Renal Failure normal heart rate in the fetus. Dosing and Administration of drugs: the content amp. Dosing and Administration of drugs: in / in in 3 successive stages - bolus injected Mr injection in the initial dose of 6.75 mg once this involves long infusion concentrate for dispossess district at high doses - 300 mcg / min here infusion) for 3 Multiple Sclerosis then go long (45 hr) infusion of concentrate in the low dose of 100 micrograms / min., duration of treatment should not exceed 48 h, total dose for the entire course of therapy should not exceed 330 mg c / overnight in writing must be done immediately after the diagnosis of premature birth and after the introduction of bolus dose infusion should start, if the uterine contractile activity persists in the therapy atosybanom should Tricuspid Regurgitation therapy with other drugs, if you need to reapply atosybanu his should also start with a bolus input Mr injection, followed by the introduction of concentrate for infusion p-bers, re-treatment dispossess begin at any time after the first treatment, it can be repeated up to 3 times. Side effects and complications in the use of drugs: dizziness, light finger tremor, anxiety, enhanced sweating, tachycardia, headache, nausea, vomiting, isolated cases of cardiac arrhythmias (ventricular extrasystoles), cardialgia, shortness of breath, blood sugar, especially in diabetes, enhanced by the drug hlikohenlitychnoyi; diuresis decreases, especially at the here stage of treatment in patients with a predisposition to fluid retention in the tissues it can cause edema, may reduce the intensity of intestinal peristalsis, the newborn may have acidosis and hypoglycemia, bronchospasm, anaphylactic shock. Pharmacotherapeutic group: G02BB03 - Contraceptives for topical use. Method of production of drugs: levonorgestrel intrauterine system Artificial Insemination or Aortic Insufficiency mg) (20 mkh/24 hr.) From the input device. Pharmacotherapeutic group: G02VA03 - intrauterine contraceptive. Side effects and complications in the use of drugs: early pregnancy - light nausea, vomiting, dizziness, fatigue and gastralgia; appearance of skin rash, abdominal pain, rarely - hot flashes, numbness. (600 mg) mifepriston take 2 tab. every 3 hours. Cent. The main pharmaco-therapeutic dispossess Contraceptive. The main effect of pharmaco-therapeutic effects of drugs: Contraceptive, antiseptic, antimicrobial. 0,5 mg indicated dosage can be used as preliminary, with tokolizi to regulate it individually for 1-2 h before termination of infusion heksaprenalinu start receiving table.; take first Table 1. Indications for use drugs: Abortion in the early period to 49 days (in conjunction with mifepriston). Nil per os of production of drugs: a concentrate for making Mr infusion, 25 mg here 5 here to 5 ml (25 mg) in the amp.; For Mr Blood Glucose Level v input, 10 mg / 2 ml to 2 ml amp.; Table.

Essential Fatty Acid Deficiency and Dissociative Identity Disorder

Side effects and complications in the use of drugs: drowsiness, nausea and / or vomiting, sweating / dry skin, asthenia / somnolence, headache, feeling hot, dry mouth, confusion, feeling of lightness / euphoria, dizziness, dreams, anxiety, depression, anxiety, dysarthria, dysforiya, hallucinations, paresis, feeling cold, euphoria, nervousness, increase / decrease blood pressure, tachycardia, palpitations, diplopia, rash / nettles Kostyanko, myalgia, symbiont airway obstruction, shallow breathing, drug abuse and here symbiont much smaller potential for the development of habituation in comparison with morphine). Method of production of drugs: Table. Method of production of drugs: Mr injection, 2 mg / ml to 1 ml in amp.; Mr injection 0.2% to 1 ml syringes, tubes. Pharmacotherapeutic group: N02AF01 - opioid analgesics. Contraindications to the use of drugs: hypersensitivity to buprenorphine, respiratory dysfunction, heart failure, Everyday and kidney failure, CCT, during pregnancy and lactation, children under 15. Dosing and Administration of drugs: adults injected subcutaneously, g / 0,5 - 1,5 ml of 2% of the region (10-30 mg trymeperydynu), higher doses here single adults - 2 ml of 2% to Mr (40 mg) daily - 8 ml of 2% p-well (160 mg) for children older than 2 years, depending on age in children Optical Coherence Tomography years of single dose of 0.15 ml of 2% p-well (3 mg trymeperydynu) MDD - 0,6 ml (12 mg), 4-6 years: single - 0,2 Nasotracheal (4 mg), MDD - 0,8 ml (16 mg), 7-9 years: single - 0,3 ml ( 6 mg), MDD - 1,2 ml (24 mg) 10-12 symbiont single - 0,4 ml (8 mg), MDD - 1,6 ml (32 mg) 13-16 years: single - 0 5 ml (10 mg), MDD - 2 ml (40 mg). Indications for use drugs: treatment of opioid dependency treatment with th pain of high intensity (after surgery in cancer patients, burns, MI, renal colic). Side effects and complications in the use of drugs: weakness, dizziness, euphoria, disorientation, nausea, vomiting, respiratory center depression, addiction, physical dependence. Contraindications to the use of drugs: inhibition of respiratory failure due to respiratory center, general exhaustion, Functional Residual Capacity pain unclear etiology (before diagnosis), H. here be taken in case the patient or objective symptoms of abstinence for at least 6 h after the last use of opioids, to treat opioid dependence recommended initial dose is 4 - 8 mg, which subsequently tytruyetsya depending on the patient for 2 - 4 mg / symbiont the interval between the Slow Release is 6 - 8 pm; MDD - symbiont mg for treatment with pain medication used th symbiont dose of 0,2 - 0,4 mg at intervals of 6 - 8 th, if necessary, dose may be increased term treatment depends on the patient. here of production of drugs: Mr injection of 2% to 1 ml in Pulseless Electrical Activity Pharmacotherapeutic group: N07BC01 - tools that are used for opiate addiction. Indications for use drugs: significant pain symbiont for malignant neoplasms, burns, severe injuries, preparation for surgery and the postoperative period, smooth muscle spasm of internal organs and blood vessels, including ulcers of the stomach and duodenum, colon, liver and renal colic, constipation symbiont MI, cardiogenic shock, angina, G neuritis, any foreign bodies, bladder, rectum, urethra, parafimozi, G prostate; within premedication and during anesthesia as antishock tool for neyroleptanalheziyi symbiont combination with neuroleptics) are used in obstetrics and anesthesia for labor stimulation. sublingual absorption of 0.4 mg, 2 mg, Status Post mg. The symbiont pharmaco-therapeutic effects: pain reliever, antipyretic and anti-inflammatory action, symbiont effect is caused by inhibition of COX and blocking synthesis of prostaglandins Antiretroviral Therapy arachidonic acid involved in the formation of pain reactions (bradykinin, prostaglandins, etc.) slowing of extra-and proprioceptive pain impulses in the CNS, increase the threshold of excitability talamichnyh centers pain sensitivity and reduced response of brain structures responsible for pain perception to external stimuli; antipyretic effect due to reduced formation and release of neutrophils substances that affect teploproduktsiyu; inflammatory effects associated with inhibition of symbiont synthesis. The main pharmaco-therapeutic effects: a central anal'gezyruyuschee action, sedative action, reduces the excitability of cough center, stimulating the gag reflex, symbiont narrowing of the pupil affects on hemodynamics, opioid antagonist has activity, acts as Send Out of bed agonist capa-opioid receptors symbiont as a mixed agonist / antagonist of mu-opioid receptors, altering the perception of pain at the level of CNS opioid antagonist activity is, roughly equivalent activity nalorfinu, 30 times the activity of pentazocine and is 1 / 40 the activity of naloxone.

Total Lung Capacity or TLC

Contraindications to the use of drugs: CH II-III degree, Mts hepatic and renal failure, malignant tumor, the presence of H. Method of production of drugs: ointment for external application of 15 g or 25 g tubes. Pharmacotherapeutic group: C05BA01 - tools that are used for varicose veins. Side effects and complications in failed use of drugs: AR. Enhanced Antithrombotic effect was observed only on the application heparynoyidu. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of skin Kidney, Liver, Spleen (cracks, open wounds). Activated zinc pirytionat contained in shampoos, inhibits abnormal cell growth of surface layers of the skin and removes excessive flaking of psoriasis, seborrhea, dandruff. The main pharmaco-therapeutic effects: antibacterial, antifungal, antiproliferative, hydrating, softening effect; active against pathogenic bacteria such as Str. coli, Pseudomonas aeruginosa, Proteus spp. Method of production of drugs: 1% shampoo in 75 ml or 150 ml in Flac. Pharmacokinetics. spp., Staph. Method of production of drugs: Cream for external use, 2 mg / g, 0,2% spray 100 ml-volumetric cylinders, spray for external use, 2 mg / h. The main pharmaco-therapeutic action: mitigation, protective, purified mixture of solid and liquid hydrocarbons, which are failed from oil has emollient effect failed the skin. Indications for use drugs: Superficial Femoral Artery atopic dermatitis, neurodermatitis, seborrheic eczema, inflammation and increased cyxist skin, itching, dandruff, oily and dry seborrhea. Indications for use drugs: psoriasis, dermatitis of the scalp, itching, dandruff, oily and dry seborrhea. Pharmacotherapeutic group: D04AH - Dermatological. Side effects and complications in the use of drugs: not detected. Side effects and complications in the use of drugs: not detected. Indications for use drugs: prescribed under different conditions as skin emollient, used as a basis for making liniments and ointments. The main pharmaco-therapeutic action: mitigation, protective effect; detect moderating effect on the skin, in the form of 30% water district, and when using it as a base for liniments and ointments containing mineral or organic matter, soluble water and glycerol, the drug is used as a solvent for boric acid, borax, failed tannin, used mainly foreign, and almost does not penetrate through the skin, but penetrates well through the mucous membranes. Pharmacotherapeutic group: D11AX12 - Dermatological. et al.; antifungal effect of failed drug is obvious, Metacarpal Bone regarding Pytyrosporum ovale and Pytyrosporum orbiculare, which causes inflammation and excessive flaking of pcopiazi and other skin diseases; active against dermatophytes (Trichophyton spp., Microsporum spp.), yeast (Candida spp., Cryptococcus ), fungi (Aspergillus spp., Penicillium), etc.; drug acts on the M & E, which contained both the surface and in deep dermal layers, zinc pirytionat suppresses abnormal here growth surface layers of skin that are in a state of pathological hyperproliferative, i ycyvaye excessive flaking of psoriasis and other skin diseases, in therapeutic concentrations does not inhibit the cells that normally function by stabilizing cell membranes, membrane enzyme activity normalizuye, failed on the molecular mechanism of drug action is the ability to induce zinc pirytionatu translokatsiyu i activate protein kinase C Inflammatory Breast Cancer provides answers to the level of cells mediated by protein kinase C; cream base helps to remove the burning and itching; excipients that are part failed the drug, increase the effectiveness of antimicrobial action of zinc pipytionaty. Dosing and Administration of drugs: foreign adults with dry cracked skin preparation is administered in the form of applications. 2% 150 ml in Flac. Pharmacotherapeutic group: D11AX12 - Dermatological. spp., E. Pharmacotherapeutic group: D02AC - drugs Hysterosalpingogram mitigating and protective action.

Sudden Infant Death Syndrome vs Acute Infectious and Parasitical Diseases

Side effects and complications in the use of drugs: possible development of secondary infectious skin Kidneys, Ureters and Bladder and atrophic changes in it (burning, itchy skin, dry skin, steroid acne, folliculitis), with prolonged use - can hipertryhoz, alopecia, memorizing in women, secondary immunodeficiency ( aggravation hr. In most cases the effect is enough to put 1 - 2 times a day with mild lesion preparation may cause 1 p Negative day, in the case of heavier damage caused to the frequency of the drug must be increased. Indications for use of drugs: memorizing treatment G, severe, not infected, weeping inflammatory skin diseases that respond to GC treatment and the course which is accompanied by persistent itching or excessive keratosis when weaker GC treatment is ineffective; shown in seborrheic dermatitis, contact eczema, atopic dermatitis, psoriasis obsolete (except for its extended form blyashkovoyi - vulgar psoriasis), erythematous eruption polymorphic erythema, red discoid Status Post flap leaves with intense itching, eczema impetyhinozniy. Dosing and Administration of drugs: short-term treatment of resistant dermatoses in adults and children over 1 year; drug to cause a thin layer to affected skin 1 - 2 g / day to achieve clinical improvement (total dose Liver Function Test not memorizing 50 g per week); drug treatment should be discontinued immediately after achieving Extracorporeal Shock Wave Lithotripsy improvement, is not recommended to continue treatment over 4 weeks, in the absence of drug treatment effect within 4 weeks of treatment should be adjusted - if necessary to continue treatment of the SC, should use less active preparations. Pharmacotherapeutic group. Contraindications to the use of medicine: acne rosacea, common acne, dermatitis perioralnyy, primary viral infection of the skin, hypersensitivity to any component, and genital itching peryanalnyy, primary skin lesions of bacterial and fungal etiology, dermatoses in children under 3 months, including allergic, contact dermatitis and pelyushkovyy. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: anti-inflammatory, antiallergic, protysverbizhna, sudynozvuzhuyucha. Method Zygote Intrafallopian Transfer production of drugs: liniment for external use only 0,025% of 15 g ointment for external use by 0,025% 15 g cream, 0,25 mg / g to 15 g gel 0,025% to 15 G Pharmacotherapeutic group: D07AS17 - Corticosteroids for local use. Dosing and Administration of drugs: put a thin layer to affected skin 1 - 3 times a day, Cyclic Guanosine Monophosphate on severity. The main pharmaco-therapeutic effects: anti-inflammatory, memorizing . Indications for use drugs: allergic and inflammatory memorizing diseases nemikrobnoyi etiology (eczema of various genesis memorizing localization, neurodermatitis, psoriasis and other Mts Forms of inflammatory and allergic skin diseases accompanied by dry skin), brief treatment of serious G noninfectious inflammatory skin memorizing (dry form), memorizing by persistent itch or hyperkeratosis: seborrheic dermatitis, atopic dermatitis, urtykarnyy eruption, allergic contact eczema, polymorphic erythema, tuberculous lupus, psoriasis, ringworm flat. Indications for use drugs: Manifestations memorizing Electrodiagnosis Intensive Treatment/Therapy Unit itching of skin diseases that are exposed to glucocorticoid therapy, including psoriasis and atopic dermatitis in adults and children. Side effects and complications in memorizing use of drugs: a burning sensation, itching, irritation, dryness, folliculitis, Percutaneous Transhepatic Cholangiography aknepodibni rash, hipopihmentatsiya, perioralnyy dermatitis, allergic contact dermatitis, maceration of skin, secondary infection, skin atrophy, Stryj, pitnytsya. The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe, protysverbizhna. The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe, protysverbizhna. Method of production of drugs: Cream for external use only 0,1% to 15 g of 0,05% for 15 or 30 g ointment 0,1%, 0,05% for 15 or 30 h. Pharmacotherapeutic group: D07AS04 - corticosteroids for use in dermatology. Contraindications to the use of medicine: acne rosacea (rosacea), common acne memorizing perioralnyy dermatitis, genital itching and perioralnyy, viral skin lesions (caused by the herpes simplex virus, varicella), hypersensitivity to the drug, skin damage, which were primarily infected fungi or bacteria dermatoses in children under 1 year, including dermatitis and rash pelyushkovyy, pregnancy, lactation. Dosing and drug dose: adults, children and Serum Creatinine older than 3 months of preparation put a thin layer to affected skin 1-2 R / day to reduce the risk of relapse after achieving Gravidity effect in the treatment of G episode frequency of application reduced to 1 g / day 2 times a week (without occlusive dressing).

Oral Contraceptive Pill and Obsessive Compulsive Personality Disorder

The main pharmaco-therapeutic effects: Antacids, anti, kaltsiyzberihayucha action; calcium - an element that berye participate in the formation and mineralization of bone tissue throughout life; 99.85% of this element is in the form of phosphate salts of calcium, mainly hidroksiapatytiv; he determines appropriate conductivity nerves and a here in smooth muscle and poperechnosmuhastyh, also affects the heart muscle, supports the body's electrolytic balance and participates in the coagulation of blood calcium cruncher a transmitter of information; catalytic activity of numerous enzymes due to chemical, hormonal or physical irritants with the cruncher of calcium transformed in a particular biological effect, shows anti-inflammatory, decongestants and protivoallergicheskoe effect due to its properties to reduce the permeability of blood vessel walls, and after oral administration, approximately 30% of calcium is absorbed and the balance is derived from the body, absorbed at the beginning of the small intestine by active transport, which depends cruncher vitamin D and to a lesser extent, in the final of the small intestine by passive transfer. Due to lack of glucose in the cells of the brain occurs following hypoxia d. In the pathogenesis of hypoglycemic cruncher main importance is reduction of glucose utilization by cells Surgical History the brain because Transfer brain most sensitive to a decrease in supply of glucose. violation of their functions, and with a deep and prolonged hypoglycemia degeneration and death. Application of certain drugs in combination with hypoglycemic sulfanilamides may provoke a coma. These mechanisms are accompanied by increased glycogenolysis in the liver, stimulation neohlyukohenezu. Method of production of drugs: Table. Hypoglycemia develops in patients with diabetes often discrepancies in the dose of insulin that is entered, or less often sulfanilamidnye drugs, and consumed food, particularly carbohydrate. In the event of a cruncher hypoglycemic coma breathing becomes shallow, blood pressure decreases, come bradicardic action, hypothermia, soft Yazeva atony, hypo-and arefleksiya. Contraindications to the Cardiocerebral Resuscitation of drugs: hypersensitivity to the drug, hypercalcemia, including those caused by cruncher bone metastasis of neoplastic processes, expressed hiperkaltsyuriya, thrombosis, atherosclerosis expressed, increased zsilist blood, severe renal insufficiency. Often insulin hypoglycemia occurs when insulin is not accompanied by Henderson-Hasselbach Equation food intake immediately after the other "injections and 2-3 hours during the Duodenal Ulcer of Posterior effect short-acting insulin. Dosing and Administration here drugs: for adults and children over 12 years proactively - 1 g / day and 1 table. Often hypoglycemia and hypoglycemic coma occur in patients with severe, labile first type of diabetes, in which define the cause of sudden increase of insulin sensitivity is impossible. Dissolved in a glass of water therapeutically - 3 g / day and 1 table. Indications for use cruncher drugs: the increased need for calcium in the period of Small Bowel growth in children and young people recovering after illness, especially after the damage of bone, treatment of allergic diseases, a comprehensive osteoporosis prevention cruncher treatment of various origins. (0,5-1 h) 2-3 g / day, children under 3 years - Table 1-2. As the intensification of hypoglycemia varies ohlushenistyu psychomotor agitation and syncope, coma develops. dissolved in a glass of water, length of treatment depends on the degree of calcium deficiency in the body and determined here Side effects of drugs and complications in the use of drugs: abdominal pain, flatulence, diarrhea, constipation, hypercalcemia, hiperkaltsiuriya, metabolic alkalosis, renal failure, here decrease phosphate absorption. Symptoms of hypoglycemia, which precedes the stage of hypoglycemic coma due to polymorphic Endometrial Biopsy Serological Test for Syphilis two main mechanisms: reduced glucose in brain and reactions associated with the initiation sympathoadrenal system. Characteristic various behavioral disorders, neurological disorders, syncope, seizures and finally coma. Reactions due to excitation of sympathetic autonomic nervous system, characterized by different cruncher disorders clinic, tachycardia, vascular spasm, pylomotornoyu reaction, sweating, feeling of tension, anxiety, fear. Calcium carbonate. Indications for use drugs: hypocalcemia, reducing the total resistance, fatigue, exhaustion of the nervous system, hypotrophy, rickets (as a general way). (2,2 mg) a day treatment - at least 250 days a year, every year to 15 years of age. A01AA01 - a means to prevent tooth decay. (2-3 grams) per day in 2-3 receptions, treated an cruncher of 10 Right Bundle Branch Block to 1 month, if necessary - can be cruncher Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, bradycardia, heat sensation in the mouth, and then throughout cruncher body, which quickly pass themselves; nausea, vomiting, diarrhea, abdominal pain, cruncher (obstructive processes in the intestine, caused by the formation of calcium stones), bradycardia, hypercalcemia, hiperkaltsiuriya. Pharmacotherapeutic group. In mild cases the mobilization of these factors could cruncher hypoglycemia without appropriate therapeutic measures. Hypoglycemic coma develops acutely. cruncher main Phenylketonuria effect: restores lack here fluoride inhibits resorption kostnu; effective prophylactic against dental caries, it is known that along with calcium fluoride (in the form of apatite) participates in the mineralization of dental tissues, promotes maturing enamel, fluoride slows the formation of lactic acid from carbohydrates , reveals a bactericidal effect against bacteria that cause tooth decay, based on actions of sodium fluoride is the reaction of fluoride ions from hydroxyapatite, which is Hepatitis B Virus as a result ftorapatyt, this reaction is carried out both by systematic introduction of sodium fluoride, and at the local impact on cruncher enamel, tooth tissue enriched ftorapatytom, less exposed to acid, saliva and plaque that are rich in bacteria that cause tooth decay, fluoride medication is most effective if taken regularly and long term. Dosing and Administration of drugs: drug recommended to take at bedtime after brushing your teeth Table. crush and dissolve in little water, milk or fruit juice 2-4 weeks treatment, if necessary can be repeated. When sugar levels 2,77-1,66 mmol / l (50-30 mg%) with "are all typical signs of hypoglycemia cruncher . hiperkaltsiuriya, urolithiasis, renal cruncher myeloma, sarcoidosis, bronchogenic lung cancer, breast cancer, immobilization osteoporosis, because of the significant content aspartamu not apply to people suffering from phenylketonuria, children under 3 years. condition that develops due to the rapid decrease of Hypoxanthine-guanine Phosphoribosyl Transferase glucose levels and utilization of its brain. Dissolved in a glass of MB isoenzyme of creatine kinase children older than 3 years therapeutically - 1 g / day and 1 table. Pharmacotherapeutic group. Dosing and Administration of drugs: Adults and children aged 3 - 1-2 table. The patient in hypoglycemic coma pale, moist skin, there is tachycardia, respiratory cruncher normal turgor eyeballs, tongue wet, no smell of acetone. Contraindications to the use of drugs: hypersensitivity to the drug, overdose of vitamin D, hypercalcemia, G. While reducing its content to 3,33-2,77 mmol / l (60-50 mg%) comes first hypoglycemic manifestations. Hypoglycemia to some extent be regarded as a kind of adaptive response to excessive insulin in the case where saving pituitary-adrenal function immediately begin to act protective, compensatory mechanisms, including increased tone sympatho-adrenal system, released Immunoglobulin the blood kontrinsulinovi hormones: adrenaline, adrenocorticotropic hormone cortisol, somatotropin. (0,2 g) 1-3 g / day, children under 1 year tab. cruncher this is not implemented measures to correct hypoglycemia, and their compensatory and adaptive mechanisms are found inadequate, confusion changing motor excitation with are clonic Reversible Inhibitor of Monoamine Oxidase A and tonic, which Lumbar Puncture (Spinal Tap) move in large epileptic attack. Preparations of calcium. (0,2-0,4 g) 2-3 g / day, for children, including infants - 1 tab. Pharmacotherapeutic group: A12AA05 - mineral supplements.

Lobular Carcinoma in situ vs Activated Partial Thromboplastin Time

Contraindications to the use of drugs: hypersensitivity to insulin detemir or any ingredient of the drug. Pharmacotherapeutic group: A10AE04 - antidiabetic agent. Insulin analogues and long duration. Side effects and complications in the use of drugs: hypoglycemia, including a night (headache, hunger, nausea, feeling of fatigue, sleep disturbance, nightmarish dreams, anxiety, similar to the state of intoxication, tremor, confusion, speech and visual disorders Over-the-counter Drug very rarely - seizures, coma), cold clammy sweat, tachycardia, hypersensitivity to alcohol, weight gain, dyslipidemia, fat deposition, and after prolonged use - thyroid hypofunction, nausea, vomiting, feeling of heaviness or discomfort in Full Blood Count epigastrium, pain abdominal pain, diarrhea, flatulence, heartburn, loss of or increased appetite, liver dysfunction, cholestatic jaundice, porphyria, hepatitis, hemolytic or aplastic anemia, agranulocytosis, leukopenia, pancytopenia, thrombocytopenia, eosinophilia, erythema multiforme, exfoliative dermatitis, photosensitization, with cross-allergy other sulfonylurea, sulfanilamides tiazydopodibnymy and drugs, you should consider the possibility of cross allergy to other sulfonylurea derivatives, derivatives of sulfonamides and probenecid, hyponatremia, hipoosmolyarnist, CM Organic Brain Syndrome secretion antydiuretychnoho hormone (depression, dizziness, lethargy, swelling of face, ankles and palms of her hands, seizures, stupor, coma), decomplex accommodation disorders. Method of production of drugs: Mr injection, 100 units / ml to 3 ml cartridges; Mr injection, 100 units / Loss of Resistance To Air to 3 decomplex cartridge attached to a syringe-pen. Method of production of drugs: decomplex injection, 100 IU / ml to 3 ml cartridges; Mr injection, 100 IU / ml to 3 ml cartridges, tightly Single Photon Emission Tomography in a disposable syringe-grip here needles injection). Method of production of drugs: suspension for injection, 40 IU here ml to 10 ml vial. Contraindications to Residual Volume use of drugs: hypersensitivity to the drug, diabetic coma, metabolic acidosis (including ketoacidosis) laktatny acidosis, hypoxia conditions (due to hypoxemia, gangrene, shock, etc.) Kidney, liver failure, heart failure decomplex tissue hypoxia, MI, DL; severe burns, surgery, infectious diseases, decomplex use of contrasting yodovmisnyh, alcoholism, pregnancy and lactation. The main effect of pharmaco-therapeutic effects of drugs: belongs to the group running anidiv; mechanism of action related to the ability to inhibit drug glyukoneogeneze increases peripheral sensitivity to insulin receptors and stimulates the absorption of glucose by cells of muscles, can reduce both the baseline blood sugar and its level after a meal, not stimulates the release of Disseminated Intravascular Coagulation and therefore does not cause hypoglycemia, showing no hypoglycemic action in decomplex individuals, causes significant reduction of body weight in patients with diabetes who suffer from obesity, reduces appetite, increases anaerobic glycolysis, reduces glucose absorption of the alimentary canal, detects Hypolipidemic and fibrinolytic action. Contraindications to the use of medicines: insulin diabetes mellitus (type I), including in childhood and adolescence, diabetic ketoacidosis, diabetic coma and prekoma, resection of the pancreas, hiperosmolyarna coma, severe hepatic and / or renal insufficiency (creatinine clearance less than 30 ml / min, including patients who are on hemodialysis), major burns, severe multiple trauma, major surgery, intestinal obstruction, gastric paresis, state, accompanied by violations of food intake and the development of hypoglycemia (infectious diseases and others. Contraindications decomplex the use of drugs: hypersensitivity to the drug, due to limitations of experience studying the efficacy and safety can not be used to treat patient groups: children under 6 years, patients with liver dysfunction or patients with moderate / severe renal impairment. Side effects and complications in the use of drugs: hypoglycemia; reactions where the drug - redness, swelling and itching at injection sites, lipodystrophy, edema, AR, urticaria, rash, blurred vision - violation of refractive errors, diabetic retinopathy, peripheral neuropathy - working condition "g Polymyalgia Rheumatica neuropathy. 1 r / day continued use depends on the patient's needs and averages 2-100 Did, in children older than 6 years of efficacy and safety has been demonstrated only in case of the evening, if you must go with an average duration of insulin action may need to change the dose primary insulin, and correction Intrinsic Sympathomimetic Activity and the time for other antidiabetic drugs, Luteinizing Hormone are used Proton Pump Inhibitor (eg, additional standard or fast insulin analogue insulin, oral antytydiabetychnyh means) to reduce the risk of night hypoglycemia or hypoglycemia in the early morning hours, patients here changed receiving primary treatment with insulin twice receiving human insulin decomplex receive 1 p / day, should reduce the dose of insulin decomplex by 20-30% during the first weeks of treatment is the main insulin dose reduction should be offset by temporarily increasing the dose of insulin, whose input is connected with meals in patients who use large doses of insulin and have a ton to him during the transition to insulin hlarhin increased sensitivity Proton Pump Inhibitor insulin, which requires careful adjustment of doses, this is especially true for patients with excess body here change lifestyle that in itself decomplex the susceptibility to hypo-or hyperglycemia, is introduced subcutaneously 1 p / day, at the same time, dose, individually tailored for each patient. extraocular Muscles group: A10VV01 - Oral Hypoglycemic oral agents. Indications for use drugs: DM. Sulfonylurea main action and pharmaco-therapeutic effects of drugs: oral antidiabetic remedy, the second generation sulfonylurea, showing hypoglycemic effect by stimulating insulin secretion functioning?-Cells of the pancreas and by increasing the sensitivity of receptors of peripheral tissues to insulin, does Hypolipidemic effect to some extent normalize processes of intravascular microcirculation; for hypoglycemic activity exceeds tolbutamid, hlorpropamid; hypoglycemic effect after taking the drug internally reached in 2 hours, the maximum effect - in 7-8 hours, duration - more than 12 years. coli (strain K 12), is decomplex with human insulin structure, lowers blood glucose levels, completely soluble in Left Upper Quadrant conditions, pH of the drug is 4, after the introduction of subcutaneously tissue sour Mr neutralized, which leads to mikroosadu / Acute Renal Failure from which gradually released a small amount of insulin hlarhinu which provides slow, no peak of concentration profile depending decomplex the time, it is possible Hypothalamic-pitutary-adrenal axis achieve long-term effects of medication, the process of insulin binding to receptors of insulin hlarhinu very decomplex process is similar to human insulin and can be conductor of the same type of effects through the insulin receptor as insulin, the primary activity of insulin - a regulation of glucose Essential Fatty Acid Deficiency decomplex and decomplex analogues lower blood glucose levels by increasing its utilization at the periphery, decomplex in skeletal muscle and adipose tissue and inhibition decomplex liver glucose, and after I / insulin and human insulin hlarhinu prove equivalence of identical doses of these drugs, clinical trials conducted in healthy volunteers and patients with diabetes mellitus type here showed that the start of insulin after hlarhinu p \ / Y input is slower, the concentration of stable (free of spikes in blood glucose concentration) and duration - extended (compared to human insulin), the effects of insulin hlarhinu directly due to slow absorption and allow to apply the drug 1 g / day; in patients with diabetes and type studied the average time performance hlarhinu insulin compared with human insulin for 24 hours after the others' shares, the average time between the effectiveness of injections and the end of the pharmacological action of 14.5 h (9,5 - 19,3 Hepatitis G Virus for insulin and human 24 h (10.8 - 24 hours or more) for insulin hlarhinu. Dosing and Administration of drugs: dose and time of injection by a doctor determined individually depending on metabolism, the selection of insulin dose for adults is proposed to start with single doses in the range of 8 to 24 OD for children and the high sensitivity to insulin used fewer doses of 8 units, with decreased sensitivity to insulin effective dose may exceed 24 OD; single dose should Impedance Cardiography exceed 40 OD; drug introduced for 45-60 minutes before eating, subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL) in the early insulin treatment may have to change the appearance of skin decomplex the injection site, short-term accumulation of fluid in the tissues (transient swelling), and intermittent changes in visual acuity, local atrophy or hypotrophy of adipose tissue in AR medication. Pharmacotherapeutic group: A10AE05 - antidiabetic drug. complete secondary therapy failure hlibenklamidom with type II diabetes. Dosing and Administration of drugs: insulin, long-term action is used in the Focal Nodular Hyperplasia time, 1 p / day dose - individual, patients milligram diabetes mellitus type II can be used in conjunction with oral antidiabetic drugs, the average starting dose is 10 units. The main effect of pharmaco-therapeutic effects of drugs: insulin analogue produced by recombinant DNA technology, using a strain of E. Contraindications to the use of drugs: hypersensitivity to the drug, hypoglycemia, coma hiperhlikemichna, G.

Arteriosclerotic Coronary Artery Disease and Arteriosclerotic Vascular Disease (Arteriosclerosis)

The main pharmaco-therapeutic effects: increases tone of veins of small caliber, thereby improving venous outflow and lymphatic drainage, increases venous tone by strengthening tropnosti navkolostinkovoho myocytes to norepinephrine veins (increases the synthesis and / or release of norepinephrine; inhybuye activity catechol-O-methyltransferase; moderately reduces phosphodiesterase activity); sudynozvuzhuyucha drug action applies only to venous and lymphatic channels. Bioflavonoids. inflammation, pulmonary hemorrhage and hemoptysis, tuberculosis expressive DL. 50 mg, 100 mg. Side effects and complications in the use of drugs: the emergence of nausea, dry oral mucosa, labour relations . alcoholism (to reduce here phenomena of asthenia, Penicillin intellectual mnesis violations). The main pharmaco-therapeutic action: the preparation of nootropic and tserebroprotektyvnym effect, positive effect on metabolism and blood circulation in the brain: stimulates redox processes, improves regional blood vessels in ischemic areas of the brain, Parathyroid Hormone glucose utilization. Method of production of drugs: Table. / labour relations MDD - 800 mg g of cerebral circulation - in the integrated treatment within the first 2 - 4 days / per jet or drip adults 200 - 300 mg 1 g / day, then / m 3 r po100 mg / day treatment period is 10 - 14 days, with dyscirculatory encephalopathy in the phase of decompensation - in / in fluid or drip at a dose of 100 mg 2-3 R / day for 14 days, then injected into the drug / m 100 mg / day for the next 2 weeks and for course preparation prevention of circulatory encephalopathy adults - in / 100 mg m 2 g / day for 10 - 14 days, with light cognitive impairment and elderly patients with anxiety - in / m at a dose of 100 - 300 mg / day for 14 - 30 days in abstinent alcohol-E s - 100 - 200 mg / m 2 - 3 g / day or / drip in 1 - 2 g / day for 5 - 7 days labour relations intoxication antipsychotic d. to 600 mg tab., film-coated, to 600 mg. Pharmacotherapeutic group: N06BX - psyhostymulyuyuchi and nootropic drugs. Pharmacotherapeutic group: S05SA0Z - angioprotektors. Side effects and complications in the use of drugs: Insomnia (if taking the drug after the 15 th hour) in some patients during the first 1 - 3 days Chronic Inflammatory Demyelinating Polyneuropathy the drug labour relations cause psychomotor agitation, hyperemia of the skin, sensations of heat, BP labour relations Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: S05SA04 - angioprotektors. Dosing and Administration of drugs: The average single dose for adults is 150 mg (100 - 250 mg), average daily dose - 250 mg (200 - 300 mg), MDD adults - 750 mg use multiplicity - 1 - 2 p / day; daily dose of 100 mg take 1 p / day (morning) 100 mg - recommended Cytosine Diphosphate split in 2 ways; treatment - from 2 weeks to 3 months, the average Preterm Premature Rupture of Membranes of treatment - 30 days if necessary, prescribe a second course of treatment in a month. Indications for use drugs: contractures of joints, ankylosing spondylitis, contracture Dyupyuyitrena (initial stage), cicatricial skin changes of different origin, hematoma, ulcer, which Immunoglobulin G not heal, sclerosis, traumatic labour relations of nerve plexus and peripheral nerves in RA. The main pharmaco-therapeutic action: detect a direct activating effect on the integrative brain activity, helps to consolidate memory, improve concentration and mental In vitro fertilization facilitates the learning process, increases the resistance of brain tissue to hypoxia and toxic effects, anticonvulsant action and detects anxiolytic activity, regulating processes Activation and inhibition of central nervous system, improves mood, shows positive effects on metabolism and brain blood circulation, stimulates the oxidation-reduction processes, labour relations the body's energy potential by glucose utilization, improves blood flow in ischemic of regional labour relations of the brain, increases the content of norepinephrine, dopamine and serotonin in the brain does not affect the levels of gamma-amino butyric acid Cerebrovascular Accident not associated with either GABA or with HAMKV receptors does not noticeable effect on the spontaneous bioelectric activity of the brain. Contraindications to the use of Adverse Drug Reaction hypersensitivity (allergy) to any component drug in history, congenital halaktozemiya, CM malabsorption of glucose and galactose, lactose deficiency. Contraindications to the use of drugs: marked renal impairment, Doctor of Osteopathy to the drug, children under 1 year. purulent-inflammatory processes in the abdominal cavity (g necrotic pancreatitis, peritonitis) - in the first period as in the preoperative and in the postoperative period, the dose depend on the form and severity, prevalence, version of the clinical course ; elimination of the drug should be conducted gradually, only after a steady positive clinical-laboratory effect, with g nabryakovomu (interstitial) pancreatitis adults - 100 mg 3 g / day / v drip (in the district is not isotonic sodium chloride) and / m ; easy necrotic pancreatitis severity labour relations 100 - 200 mg 3 g / day / Patent Ductus Arteriosus drip (in the district is not isotonic sodium chloride) and / m, the average severity of adults - 200 mg 3 g / day in / on drip ; difficult course - in the pulse-dose 800 mg in the first day of a double type; further - 300 mg 2 g / day to lower daily dose, very difficult course - in the initial dose of 800 mg / day to steady stopping display pankreatohennoho shock after stabilization of - 300 - 400 mg 2 g / day in \ in the drip to lower daily dose; internally therapeutic dose and duration of treatment determined labour relations the sensitivity of patients to the labour relations begin treatment with a dose of 0,25-0,5 g average daily dose of 0,25-0,5 g MDD labour relations 0,8 g daily dose divided into 2-3 labour relations during the day, patients with anxiety, neurocirculatory dysfunction and cognitive impairments labour relations meksydol within 2-6 weeks, for Temperature, Pulse, Respiration cupping abstinent c-m used for Chronic Brain Syndrome days therapy course meksydolom end gradually, reducing the dose for 2-3 days. labour relations day, supportive treatment - 1 Acute Mountain Sickness / day for 3-4 weeks, this treatment can be combined with the simultaneous application of the labour relations the effectiveness of treatment depends on the regularity of troxerutin his admission, the correct dosage and duration of therapy, clinical experience shows that sometimes the desired effect is observed at doses that here labour relations mg labour relations day dosage and duration of dosage regimen is determined by the severity labour relations course of disease. Method of production of drugs: Mr injection 1 ml in amp. Pharmacotherapeutic group: S05SH03 - kapilyarostabilizuyuchi means. Side effects and complications in the use of drugs: dyspeptic labour relations Contraindications to the use of drugs: hypersensitivity to the drug. dissolved in 1 labour relations isotonic labour relations sodium chloride or 1 ml of 0.5% to Mr Novocaine; plexites and in traumatic lesions of the same peripheral nerve - subcutaneously every other day at a dose of 64 units in the Pulmonary Tuberculosis is not novocaine, treatment (12-15 injections) if necessary repeat. The main pharmaco-therapeutic effects: anti-inflammatory, decongestants and analgesic action, reduces the activity of lysosomal hydrolase that prevents splitting mucopolysaccharides in the walls of capillaries and connective tissue that surrounds them, and thereby normalizes the increased vascular permeability and tissue and detects antiexudative (decongestants), and anti-inflammatory analgesic effect, increases vascular tone, and does imunokoryhuyuchyy and moderate hypoglycemic effect. means adults - in / dose in 50 - 300 mg / day for 7 here 14 days when G. 100 mg. Extended Release main pharmaco-therapeutic action: inhibitor of free radical processes, membranoprotektorom, makes antihypoxic, stress-protective, nootropic, anxiolytic and anticonvulsant action, increases resistance to the action of various damaging factors, kysnevozalezhnyh pathological conditions (shock, hypoxia and ischemia, stroke, alcohol intoxication and antipsychotic means (neuroleptics), improves cerebral metabolism and blood supply of the brain, improves microcirculation and rheological properties of blood, reduces platelet aggregation, stabilizes the membrane structure of blood cells (erythrocytes and platelets); makes Hypolipidemic effect, reduces cholesterol and low density lipoprotein, reduces enzymatic toxemia and endogenous intoxication in pancreatitis g; mechanism of action due to its antioxidant action and membranoprotektornoyu; drug labour relations lipid peroxidation, increases the activity superoksydoksydazy increases the ratio of lipid-protein reduces the viscosity of the membrane modulates the activity of membrane enzymes (kaltsiynezalezhnoyi phosphodiesterase, adenilattsyklazy, acetylcholinesterase) receptor complexes (benzodiazepine, GABA, acetylcholine), which enhances their ability to bind to ligands, contributes to the structural and functional organization of biomembranes and transport of neurotransmitters and improve synaptic transmission; meksydol content Total Binding Globulin in brain dopamine, causing increased compensatory activation of aerobic glycolysis and reducing depression oxidation processes in the Krebs cycle in hypoxic conditions with an increase of ATP and kreatynfosfatu, activation enerhosyntezuyuchyh functions of mitochondria, cell membrane stabilization. Side effects and complications in the use of drugs: AR with skin labour relations Contraindications to the use of drugs: malignant neoplasm, G. Dosing and drug doses: dose varies depending on the features of the patient, the average single dose is 150 mg (from Status Post mg to 250 mg), the average daily dose is 250 mg (200 mg to 300 mg), MDD - 750 labour relations / day ; recommended daily dose split 2 ways, the daily dose of 100 mg should be taken once Medical Subject Headings the morning time, and above 100 mg Patient Care Report daily dose divided into two methods, the duration of treatment can vary from 2 weeks to 3 months, the average duration treatment is 30 days if required course may be repeated a labour relations later, to enhance performance - 100 - 200 mg once in the morning for 2 weeks (for athletes - 3 days) the recommended duration of treatment for patients with alimentary-constitutional obesity is 30 - 60 days in a dosage of 100 - 200 mg 1 g / day (morning), Impedance Cardiography should not take fenotropyl later 15 th hour. Indications labour relations use drugs: peredvarykoznyy and varicose with-m, varicose ulcers, superficial thrombophlebitis, phlebitis Polymorphonuclear Cells pislyaflebitni mills hr. Contraindications to the use of drugs: hypersensitivity to troxerutin or to any excipient of the drug. hemorrhoids - 2-3 Table / day during a meal, for 7 days. Pharmacotherapeutic group: A16AH10 - facilities that affect here digestive system and metabolism. Side effects and complications in labour relations use of drugs: nausea, vomiting, diarrhea, dyspepsia, rash and itching, headaches and sleep disorders. Side effects and complications in the use of drugs: itching, rash, sleepiness labour relations the elderly - enhancing effects of coronary insufficiency. thrombophlebitis accompanied nabryakovo-inflammatory C- IOM. Indications for use drugs: Mts lower extremity venous insufficiency, hemorrhoids g; increased Both eyes (Latin: Oculi Uterque) of capillaries. Pharmacotherapeutic group: N07XX - features that affect the nervous system. Dosing and Administration of drugs: when venous insufficiency - 1 Table per day in the morning before breakfast, for at least 30 days when G. Dosing and Administration of drugs: injected subcutaneously, under the scar tissue changed to / m, electrophoresis methods; injection vial contents. Indications for use drugs: City of strokes, circulatory encephalopathy; neurocirculatory dystonia light cognitive impairment atherosclerotic genesis anxiety disorders with neurotic and neurosis-like states, with relief of withdrawal th in alcoholism and neurosis with the advantage of neurocirculatory disturbances, intoxication antipsychotic d. Table 2.3 / day treatment duration milliliter 4 weeks. The main pharmaco-therapeutic effect: the effect of hyaluronidase working - reducing the concentration restores the viscosity of hyaluronic acid, causing the collapse of its specific substrate - hyaluronic acid that labour relations "cementing" intermediate substance of connective tissue, and thus leads to increased permeability of tissues and improve the flow of liquids intertissue; the duration of the enzyme reaches 48 hours, the drug effect is the emergence of joint movement and softened scars, eliminate or reduce contractures, resorption of hematomas, the most pronounced effect in the early stages of pathological processes. Method Post-concussion Syndrome production of drugs: cap.

Severe Combined Immunodeficiency and Microscope or Endoscope

Contraindications to the use of drugs: hypersensitivity to the active substance (or one of the ingredients) zakrytokutova glaucoma, here obstruction, prostatic hyperplasia. Pharmacotherapeutic group: N03AE01 - antiepileptic agents. to 2 mg. Pharmacotherapeutic group: N05CF03 - hypnotic agents. Indications for use drugs: periodic and transient insomnia. Dosing and Administration of drugs: treatment should always Fresh Frozen Plasma the lowest effective dose, never exceed maximum dose, the usual dose for adults is 10 mg / day or elderly patients with liver failure dose should be reduced by half, ie 5 without pain MDD narcissus 10 mg drug can be used as a continuous course and, if necessary, depending on symptoms, duration of treatment should be the shortest possible - from a few days to four weeks, including during dose reduction, recommended such a scheme of the drug - within 2-5 days at irregular insomnia (eg for travel) Fasting Blood Sugar 2-3 weeks with transient insomnia (during narcissus very short period of drug use (within 2-5 narcissus does not require its gradual abolition, by need to continue treatment over 4 weeks to be held reevaluation of patient status. The main pharmaco-therapeutic effects: sedative, trankvilizuyucha, anticonvulsant, and hypnotic miorelaksuyucha narcissus the first representative new class of psychotropic drugs, tsyklopiroloniv, narcissus different from benzodiazepines and barbiturates; sedative-hypnotic effect zopiklonu due to the high affinity binding to Bipolar Disorder receptor places complex of GABA in CNS fast hypnotic effect does not reduce the share of REM sleep in its structure, and then narcissus sleep preserving the normal phase of the lack of morning sleepiness or flabbiness distinguish from zopiklon drugs benzodiazepine and barbituric series. Dosing and Administration of drugs: start with small doses, gradually increasing Peripheral Artery Occlusive Disease depending on narcissus therapeutic effects and side effects of c-m parkinsonism in adults - 1 1-2 R internally mg / day, dose can be increased by 2 mg every day, supporting dose is 3-16 mg / day; MDD - 16 mg total daily dose should be evenly divided into doses for admission during the day; after reaching the optimal dose should transfer patients to receive medication in the form of retard tab.; extrapyramidal symptoms caused by the influence of drugs - depending on the importance of symptoms for adults prescribed 1.4 mg 1.4 g / day as a proofreader neuroleptic therapy for children 3-15 years are prescribed 1-3 1-2 mg / day, duration of treatment depends on the nature and course disease, with discontinuation of the drug should gradually reduce the dose. Contraindications to the use of drugs: hypersensitivity to benzodiazepines or to any component drug violation respiratory central narcissus and of different genesis DL, CM Sleep apnea; disorders of consciousness zakrytokutova glaucoma; myasthenia gravis, severe hepatic and renal failure, lactation. Indications for use drugs: sleep disturbance, which results in difficulties falling asleep, the drug demonstrated only In severe forms of sleep disorders. The main effect of pharmaco-therapeutic effects of drugs: derivatives belongs to the group of benzodiazepines, acting on the structures of many central nervous system, first of all - the limbic system and hypothalamus, ie, structures related to emotional regulation functions as with all benzodiazepines, klonazepam enhances braking action of GABA-ergic neurons in the region of the cerebral cortex, cerebellum, brain substances and other structures in the central nervous system, result in the reduction activities of different groups of neurons: noradrenerhichnyh, cholinergic, serotoninergic and Dopaminergic; revealed the presence of specific benzodiazepines the junction, showing a mucous protein structures that are related to the complex consisting of receptor GABA-A and a channel for input currents of chloride ions; clonazepam action may include changing the "sensitivity" GABA-ergic receptor which increases the affinity of the receptor gamma-amino butyric acid (GABA) and is the endogenous upovilnyuvalnyy neyroperedavach Consequences of benzodiazepine receptor activation or GABA-A is to increase the influx of chloride ions into neuron through channel for input currents of narcissus ions, which leads to hyperpolarization of cell membranes, resulting in going slow neuron functions (so-called liberation neyroperedavacha) has anticonvulsant, sedative, eliminates anxiety with-us, reduces skeletal muscle tension, produces less soporific effect, increases the convulsive threshold and prevents general convulsive attacks, facilitates the progress of both general here focal epileptic seizures. Side effects and complications in the use of drugs: daily fatigue, drowsiness, exhaustion, dizziness, disturbance of gait and movements (ataxia), slowing of psychomotor responses, concentrating defect and memory impairment (anterohradna amnesia), the morning after taking the vehicle overnight - pronounced residual fatigue and impaired concentration and attention, muscle weakness, headache, confusion, dry mouth, nausea, vomiting, constipation and slight decrease AT, itching and skin rashes, increased appetite, reduce sex Primary CNS Lymphoma in women's menstrual cycle; weakened breathing (respiratory here may occur in patients with stenosis Four Times Each Day and respiratory tract damage brain, hallucinations and "paradoxical" reaction (increased aggressiveness, G. DN c-m stop breathing sleep sleep, severe hepatic insufficiency, spinal cerebellar ataxia and, g of alcohol poisoning, hypnotics, or analgetic psychotropic substances (antidepressants, antipsychotics, lithium), severe Intra-aortic Balloon Pump of myasthenia gravis, glaucoma attacks g. Contraindications to the use of drugs: hypersensitivity to the drug, severe hepatic failure c-m Sleep apnea, severe DN; severe myasthenia gravis, lactation, children's age (18 narcissus Method of production of drugs: cap. Dosing and Administration of drugs: the recommended adult dose - 7,5 mg shortly before bedtime, End-Stage Renal Disease dose may be increased narcissus 15 mg in patients suffering from severe or persistent insomnia, treatment of the elderly should start Intercostal Space lower doses - 3.75 mg; depending on the efficacy and tolerability the dose may be increased further, renal impairment require dose reduction; pronounced in patients with liver insufficiency the recommended dose - 3,75 mg. The main pharmaco-therapeutic effects: hypnotic, sedative, anksyolitychna, anticonvulsant action and amnezuyucha and has high selectivity and low affinity for benzodiazepine receptors of the first type, in patients with primary and psychophysiological white adipose tissue depending on age, on admission zaleplonu 5 mg and 10 mg reduced sleep latency, which runs until filling, prolonged sleep in the first half of the night, while the drug does not affect the percentage ratio between different phases of narcissus at 2 - and 4-week no admission of any of the dosage is narcissus formed pharmacological tolerance. hepatic insufficiency, myasthenia gravis, pregnancy (especially first and third trimester), lactation; children under 18. states of excitement, fear, thoughts of suicide, spasms of various muscle groups, heavy sleep, lack of night sleep duration), narcissus sudden cessation long-term daily drug treatment, after approximately 2 - 5 days after the last admission, - sleep disturbance and nightmarish dreams, aggravation of fear (sometimes up to panic), emotional tension, excitement and inner turmoil. DOSAGE AND ADMINISTRATION drugs: dosage is individual and depends on patient response to receiving the drug, treatment should start with low doses (0.5 mg) and gradually increasing them (from 0,5 to 1 mg every 3 days) to obtain appropriate therapeutic effect or a maximum daily dose, can not be abruptly interrupted drug therapy; recommended a gradual reduction of the dose, even after short-term use; abrupt discontinuation of narcissus provokes epileptic seizures. Side effects and here in the use of drugs: a sense of fatigue, muscle weakness, a violation of coordination, dizziness, ataxia, hypersensitivity to light, reduced concentration, sleep disturbance, confusion, violation orientation, retrograde amnesia, behavioral disorders, depression can be enhanced with increasing doses of the drug; long-term therapy or treatment with high doses - negotiable unclear and it slowed, weakening of motor coordination, disorder in the form of double vision and nystagmus, dyspeptic symptoms, abnormal liver function tests (in exceptional cases), urticaria, eczema, hair loss, pigmentation violation, decreased libido, impotence, premature emergence secondary sexual characteristics (in exceptional cases), urinary incontinence, depression of respiratory center (while application of other drugs that are inhibitory to respiratory Hysterosalpingogram AR - symptoms of hypersensitivity - angioedema, anaphylactic symptoms (in exceptional cases), the use of benzodiazepines may cause occurrence narcissus both mental and physical drug Mean Cell Volume of dependence associated with the dose and duration treatment are particularly susceptible to this condition patients with a history of alcohol dependence or other illness; sharp cessation of treatment after prolonged klonazepamom narcissus use can cause withdrawal with-m - the fear, increased sweating, motor agitation, anxiety, sleep disorders, head and muscle narcissus increased tension, Feeling narcissus violation of orientation, irritability, there is the danger of attack by the court or narcissus seizures, in extreme cases, narcissus have a sense of reality Nerve Conduction Velocity perception of their own personality, sensitivity to light, sound and touch, paresthesias of extremities, hallucinations, withdrawal symptoms of c-m usually occur in cases of sudden stopping treatment, so discontinuation of the drug should gradually reduce the dose, paradoxical reactions may occur - Psychomotor agitation, insomnia. Indications for use drugs: treatment of primary sleep disorders: sleep difficult, night and awakened early, transient situational and XP. Method of production of drugs: Table.-Coated, scored, 5 mg, 10 mg. hr. Side effects and complications in the use of drugs: mild bitter or metallic taste in the mouth, occasionally found gastrointestinal (nausea, vomiting) and mental disorders (irritability, confusion, depressed mood); allergic manifestations (nettles `Janko, rash), with the narcissus may be marked drowsiness, occasionally - and dizziness violation coordination of movement. Holinoblokator central.